PTC logo

PTCNASDAQ: PTC

Profile

Sector:

Technology

Country:

United States

IPO:

08 December 1989

Next earnings report:

06 November 2024

Last dividends:

N/A

Next dividends:

N/A
$22.37 B
-1%vs. 3y high
89%vs. sector
-21%vs. 3y high
82%vs. sector
-8%vs. 3y high
81%vs. sector
-3%vs. 3y high
86%vs. sector

Price

after hours | 29 min ago
$186.22+$1.75(+0.95%)

Dividend

No data over the past 3 years
$518.64 M$620.53 M
$518.64 M$68.98 M

Analysts recommendations

Institutional Ownership

PTC Latest News

PTC Therapeutics to Participate at Upcoming Investor Conferences
prnewswire.com04 November 2024 Sentiment: -

WARREN, N.J. , Nov. 4, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: UBS Global Healthcare Conference Wednesday, Nov. 13 at 2:45 p.m.

PTC Inc. (PTC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
zacks.com01 November 2024 Sentiment: POSITIVE

Assess the anticipated performance of PTC Inc. (PTC) for the quarter that ended in September 2024. Instead of just focusing on the usual revenue and profit predictions from Wall Street, let's take a closer look at some important metrics for a deeper understanding.

PTC Inc. (PTC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
zacks.com30 October 2024 Sentiment: NEUTRAL

PTC Inc. (PTC) lacks the necessary elements that could lead to a strong earnings report in the near future. Be ready for the main expectations.

Vishay Intertechnology High Energy Inrush Current Limiting PTC Thermistors Increase Performance in Active Charge and Discharge Circuits
globenewswire.com30 October 2024 Sentiment: POSITIVE

Self-protecting devices are designed to handle energy levels of up to 340 J, with resistance values of 1.5 kΩ and can operate at high voltages of 1200 VDC. These devices help to reduce the number of components needed in a system. This combination enhances efficiency and safety in electrical applications.

PTC Therapeutics Announces FDA Acceptance of Translarna™ NDA Resubmission
prnewswire.com30 October 2024 Sentiment: POSITIVE

WARREN, N.J., Oct. 30, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced that the U.S. Food and Drug Administration (FDA) will review the resubmitted New Drug Application (NDA) for Translarna™ (ataluren), which is intended to treat nonsense mutation Duchenne muscular dystrophy (nmDMD).

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com25 October 2024 Sentiment: POSITIVE

WARREN, N.J., Oct. 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced that on October 23, 2024, it granted non-statutory stock options for a total of 13,690 shares of its common stock and 20,250 restricted stock units (RSUs) to nineteen new employees. Each RSU will convert into one share of common stock once it vests.

PTC Therapeutics Announces FDA Target Regulatory Action Date for Sepiapterin and Lancet Publication of Phase 3 Trial Results
https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-fda-target-regulatory-action-date-for-sepiapterin-and-lancet-publication-of-phase-3-trial-results-302275590.html14 October 2024 Sentiment: POSITIVE

WARREN, N.J., Oct. 14, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) revealed today that the FDA has scheduled a target date of July 29, 2025, to review the New Drug Application (NDA) for sepiapterin, following a typical review schedule.

PTC Therapeutics Announces Positive Results from Long-Term Treatment Studies and Updates on Regulatory Progress for Vatiquinone Friedreich Ataxia Program
prnewswire.com08 October 2024 Sentiment: POSITIVE

- The long-term study analyses showed statistically significant results for the main goal. - After receiving feedback from the FDA before the NDA submission, the timeline is set for December 2024. - On October 8, 2024, PTC Therapeutics, Inc. (NASDAQ: PTCT) shared several encouraging updates regarding their vatiquinone program for Friedreich ataxia (FA).

PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients
prnewswire.com01 October 2024 Sentiment: POSITIVE

WARREN, N.J., Oct. 1, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced that the FDA has accepted the New Drug Application (NDA) for sepiapterin, which is intended to treat both children and adults with phenylketonuria (PKU).

Will PTC's AWS Partnership to Enhance Onshape Drive Stock Upward?
zacks.com26 September 2024 Sentiment: POSITIVE

PTC Inc. has signed a Strategic Collaboration Agreement with Amazon Web Services (AWS) to support the development of its Onshape solution. This partnership is designed to improve Onshape's features, encourage more customers to use it, and advance AI projects, all aimed at helping designers and engineers produce high-quality products faster and more effectively.

What type of business is PTC?

PTC Inc. is an international software company headquartered in Boston, Massachusetts, that develops and provides computer software and services. It was founded in 1985. The company's product portfolio includes four technology platforms consisting of products for 3D project modeling (Creo), product lifecycle management (Windchill), data orchestration (ThingWorx), and augmented reality (Vuforia Studio, Expert Capture). The company generates revenue through software subscriptions, which include access to licenses and their support (technical support and software updates), support for existing perpetual licenses, professional services (consulting, implementation, and training), and cloud services.

What sector is PTC in?

PTC is in the Technology sector

What industry is PTC in?

PTC is in the Software Application industry

What country is PTC from?

PTC is headquartered in United States

When did PTC go public?

PTC initial public offering (IPO) was on 08 December 1989

What is PTC website?

https://www.ptc.com

Is PTC in the S&P 500?

Yes, PTC is included in the S&P 500 index

Is PTC in the NASDAQ 100?

No, PTC is not included in the NASDAQ 100 index

Is PTC in the Dow Jones?

No, PTC is not included in the Dow Jones index

When was PTC the previous earnings report?

No data

When does PTC earnings report?

The next expected earnings date for PTC is 06 November 2024